CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy
Nada Khairi YounisCollege of Pharmacy, Alnoor University, Mosul, Iraq. [email protected]Ali Fawzi Al-HussainyCollege of Pharmacy, Ahl al bayt University, Karbala, IraqS. Renuka JyothiDepartment of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, IndiaPriya Priyadarshini NayakInstitute of Medical Sciences and Sum HospitalJ. Bethanney JanneyDepartment of Biomedical, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, IndiaGurjant SinghDepartment of Physiotherapy, University Institute of Allied Health Sciences, Chandigarh University, Chandigarh, Punjab, IndiaDjamila PolatovaScientific-Practical Medical Center for Pediatric Oncology, Hematology and Immunology, Tashkent, UzbekistanHayder Naji SameerCollage of Pharmacy, National University of Science and Technology, Dhi Qar, 64001, IraqRasim M. SalihDepartment of Pharmacy, Al-Zahrawi University College, Karbala, IraqMohaned AdilPharmacy College, Al-Farahidi University, Baghdad, Iraq
Ochiq kirish: yoʻq
ABI
Annotatsiya
Annotatsiya mavjud emas.
Mavzular
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos130 ta foydalanilgan manba